DOI 10.3389/fcell.2026.1839015
Mesenchymal stem cells and derived extracellular vesicles in major respiratory diseases: from multifaceted molecular mechanisms to clinical perspectives.
Аннотация
Mesenchymal stem cells (MSCs), a type of pluripotent stem cells, exhibit remarkable therapeutic properties in the treatment of various diseases. Recent findings on the development of respiratory illnesses indicate that local MSCs might transform into myofibroblasts, thereby resulting in the emergence of respiratory disorders. Nonetheless, both preclinical and clinical studies on autologous or allogeneic MSC infusion reveal that MSCs can mitigate the onset of respiratory disease by controlling inflammation, restoring impaired tissues, modifying the ECM, and regulating stress-induced cell death after implantation. Furthermore, a variety of animal models have been created to explore the underlying mechanisms of various respiratory illnesses and assess the early-stage efficacy of MSC treatment in these conditions. In summary, the article examines the divergent functions of MSCs in respiratory illnesses and summarizes current perspectives on their therapeutic mechanisms in these diseases.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.